PDCD1 and neoplasm: In another study, the research was expanded and the effectiveness of PD-1 blockade was evaluated in 12 different tumor types with MMR deficiency at an advanced stage and it was seen that 21% of the patients had a complete response and 53% of the patients had an an objective radiological response [38].